ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)
Public ClinicalTrials.gov record NCT02931175. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Multi-center, Randomized, Phase II Study of the Safety,Efficacy and Bioactivity of Two Dose Regimens of Subcutaneous Injections of ACTH Gel in Patients With Non-infectious Uveitis
Study identification
- NCT ID
- NCT02931175
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Quan Dong Nguyen
- Other
- Enrollment
- 28 participants
Conditions and interventions
Conditions
Interventions
- ACTH gel Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 9, 2017
- Primary completion
- Apr 2, 2020
- Completion
- Oct 27, 2021
- Last update posted
- Dec 16, 2025
2017 – 2021
United States locations
- U.S. sites
- 7
- U.S. states
- 4
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retina Vitreous Associates, Medical Group | Los Angeles | California | 90017 | — |
| Stanford University | Palo Alto | California | 94303 | — |
| Metropolitan Eye Research and surgery Institute | Waltham | Massachusetts | 02451 | — |
| Retina Centers Professional Corporation - RCPC | Cleveland | Ohio | 44139 | — |
| Retina Consultants of Houston | Bellaire | Texas | 77401 | — |
| Texas Retina Assiciates | Dallas | Texas | 75231 | — |
| TExas Retina Associates | Dallas | Texas | 75231 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02931175, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 16, 2025 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02931175 live on ClinicalTrials.gov.